slides · global inventory
Solution
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 8,880
Current window 4,561-4,590
Pages 296
Rows per page 30
Slide type
4,561-4,590 of 8,880
28
The slide uses a biological pathway diagram to illustrate the mechanism of action for SHP2 inhibitors.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank 1 hit
29
The slide uses a table to contrast the target (SHP2) against a panel of off-target phosphatases.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank 1 hit
41
The slide presents preclinical efficacy and safety data for the lead candidate ERAS-3490.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank 1 hit
42
The slide highlights the technical challenge of targeting the active GTP state and introduces specific programs (ERAS-4 and ERAS-2/3) to address this.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank 1 hit
08
Includes a comparison to Exact Sciences' ColoGuard as a market positioning anchor.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations Beat · Solution1 hit
05
Uses a Venn diagram to illustrate the intersection of two critical clinical challenges.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank Beat · Solution1 hit
07
Uses a visual comparison diagram to explain the mechanism of action and clinical benefit of selectivity.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank Beat · Problem1 hit
10
The slide features a 3D molecular rendering showing the inhibitor (pink) bound to the target protein (blue).Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
17
Includes a heatmap table for IC50 values and two line charts showing tumor volume reduction in PDX models.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
19
The kinome tree is a standard visualization in pharmacology for kinase selectivity.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
20
The slide highlights CNS activity via brain penetration, a key component of the NVL-520 target product profile.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
24
The slide uses a high-quality 3D molecular rendering to illustrate the mechanism of action.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
32
The slide uses a kinome tree diagram to visualize selectivity. The table defines the selectivity index based on IC50 ratios.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
35
The slide uses a hexagonal process flow diagram to illustrate the three-step methodology.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
36
The slide uses a side-by-side comparison structure to highlight the target product profiles for ALK IXDN Resistance Mutations and HER2 Exon 20 Insertions.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
39
The slide features a 3D molecular structure visualization, likely a protein-ligand complex.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
05
The slide uses a hub-and-spoke diagram to illustrate MYC's regulatory reach and a line chart to show efficacy.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 1 hit
06
Uses a biological analogy of an 'operating system' to explain gene regulation.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 1 hit
07
The slide uses a four-column layout to define the platform's technological pillars.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 1 hit
08
The slide depicts a biological mechanism involving DNA structure and protein interaction, likely related to gene regulation.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 1 hit
09
The slide uses a biological diagram to illustrate the interaction between the OEC protein complex and the DNA structure.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 1 hit
10
The slide uses a process flow diagram to show the transition from a diseased state to a restored state via OEC intervention.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 1 hit
17
The chart shows a log-scale significance plot across chromosomes 1-22, highlighting a single outlier point.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 1 hit
18
The slide uses three distinct charts to show tunability (bar chart) and durability (two line charts over time).Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 1 hit
19
Shows mechanism of action: OEC targets EpiZip -> downregulates MYC -> apoptosis in cancer cells, but not in normal cells.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 1 hit
27
The chart demonstrates that the therapeutic intervention successfully crosses the therapeutic threshold, suggesting potential for hair growth enhancement.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 1 hit
33
The slide uses a hub-and-spoke diagram to map specific delivery sites (brain, lung, liver, joint, tumors) to corresponding imaging results.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 1 hit
15
The slide uses a layered architecture diagram showing data processing at the bottom, analytics/applications in the middle, and specific use cases at the top.Planet | SPAC Presentation Deck | 51 slides · Planet
Pitch deck Investment bank Beat · Solution1 hit
09
The slide uses an infinity loop diagram to represent the interconnected nature of the three platforms.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Solution1 hit
10
The slide uses a bottom-up flow to connect capabilities to strategic outcomes (Speed, Safety, Cost, Quality, Efficacy).Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Solution1 hit